icon
0%

Keysight Technologies KEYS - News Analyzed: 3,885 - Last Week: 100 - Last Month: 499

↗ Keysight Technologies (KEYS)- A Long-term Bio-tech Investment Prospect Facing Short-term Headwinds

Keysight Technologies (KEYS)- A Long-term Bio-tech Investment Prospect Facing Short-term Headwinds

There have been numerous noteworthy developments in Keysight Technologies (NYSE:KEYS). The investment firm Twin Tree Management LP has reduced its holdings, while Empowered Funds LLC's invested $914,000. KCM Investment Advisors and Norden Group LLC increased their stakes, but Swiss National Bank and ProShare Advisors LLC decreased holdings. Q1 2025 earnings per share expected is $1.41. KEYS is severing up its simulation portfolio for space application, but insiders selling $6.3m of stock may indicate caution. The company's moves are said to be multiplying its share price. Forecasted financial performance implies revenue and profit decline, yet it surpassed Q2 earnings and revenue estimates. Institutional shareholders control 89% of the company, and if investing five years ago, you would have a 63% gain. The balance sheet health appears sound. KEYS is pushing for AI deployment in RAN and has products lined up, including a PCIe designer and Chiplet PHY designer. Weak demand threatens full valuation, and it features critical SWOT insights. This company has been able to generate good shareholder returns despite some market challenges. Despite recent underperformance, KEYS remains a long-term growth prospect. It recently received a Globee® Award for customer excellence.

Keysight Technologies KEYS News Analytics from Fri, 18 Aug 2023 07:00:00 GMT to Sun, 21 Jul 2024 13:48:12 GMT - Rating 2 - Innovation -3 - Information 6 - Rumor -2

The email address you have entered is invalid.